NeuroMetrix, Inc. short interest in 2024
In 2024, NeuroMetrix, Inc.'s disclosed short interest ran from 2.16% of shares outstanding on 29 Feb 2024 to 1.05% on 13 Dec 2024, a change of -1.11 percentage points. The year's high was 2.16% on 29 Feb 2024 and its low 0.57% on 28 Mar 2024, averaging 1.14% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.44 days on 13 Dec 2024. Full history: NeuroMetrix, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2024 in figures
- Start of year
- 2.16% (29 Feb 2024)
- End of year
- 1.05% (13 Dec 2024)
- Change
- -1.11 pp
- High
- 2.16% (29 Feb 2024)
- Low
- 0.57% (28 Mar 2024)
- Average
- 1.14%
- Highest days to cover
- 3.44 (13 Dec 2024)
- SEC filings marked
- 7
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 29 Feb 2024 | 2.16% | 1.00 | results (8-K) |
| 15 Mar 2024 | 1.17% | 1.00 | 10-K filed |
| 28 Mar 2024 | 0.57% | 1.00 | |
| 30 Apr 2024 | 0.82% | 1.00 | |
| 15 May 2024 | 0.69% | 1.00 | 10-Q filed |
| 31 May 2024 | 0.85% | 2.20 | |
| 14 Jun 2024 | 0.88% | 2.60 | |
| 28 Jun 2024 | 1.17% | 2.64 | |
| 15 Jul 2024 | 1.03% | 2.77 | |
| 31 Jul 2024 | 1.49% | 2.57 | |
| 15 Aug 2024 | 1.11% | 1.00 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 1.39% | 2.18 | |
| 13 Sep 2024 | 0.66% | 1.00 | |
| 30 Sep 2024 | 1.11% | 1.00 | |
| 15 Oct 2024 | 1.04% | 1.69 | |
| 31 Oct 2024 | 0.78% | 1.05 | |
| 15 Nov 2024 | 2.08% | 1.74 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 1.52% | 1.92 | |
| 13 Dec 2024 | 1.05% | 3.44 |
See also: NeuroMetrix, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.